Hyperbaric oxygen therapy reduces the neuroinflammation and oxidative stress driving Complex Regional Pain Syndrome
Hyperbaric oxygen therapy reduces the neuroinflammation and oxidative stress driving Complex Regional Pain Syndrome
Understanding CRPS and how HBOT addresses its neuroinflammatory and vascular mechanisms
Complex Regional Pain Syndrome (CRPS) — previously called Reflex Sympathetic Dystrophy (RSD) or causalgia — is a chronic pain condition characterized by severe, disproportionate pain in a limb that persists or worsens after an injury and is accompanied by autonomic, inflammatory and trophic changes. It is classified into two types: CRPS Type 1, which develops without confirmed nerve injury (the more common form, often following fractures, sprains or surgery); and CRPS Type 2, which follows confirmed peripheral nerve damage.
CRPS is often described as one of the most painful conditions known to medicine. The McGill Pain Scale — the standard measure of pain severity across conditions — rates CRPS pain above childbirth, amputation and cancer pain. Its defining features include:
- Severe, continuous burning pain disproportionate to any precipitating injury
- Allodynia — intense pain from stimuli that should not be painful (light touch, temperature change)
- Hyperalgesia — exaggerated pain response to normally mild painful stimuli
- Autonomic changes — abnormal sweating, color and temperature changes in the affected limb
- Trophic changes — altered skin texture, hair and nail growth, and muscle atrophy
The pathophysiology of CRPS involves an abnormal central and peripheral sensitization process driven by neuroinflammation, sympathetic nervous system dysregulation, oxidative stress and microvascular dysfunction in the affected limb. This creates a self-perpetuating pain cycle that standard analgesics, sympathetic nerve blocks and even spinal cord stimulation often fail to adequately control.
HBOT addresses the biological substrate of CRPS — suppressing the neuroinflammatory cascade, reducing oxidative stress in sensitized neural tissue, restoring oxygenation to the ischemic limb and supporting nerve repair through neurotrophic factor upregulation. Published randomized controlled trial evidence confirms significant improvements in pain, allodynia and function in CRPS patients following HBOT.
Severe burning, throbbing or aching pain in the affected arm or leg
Allodynia — extreme pain from light touch, clothing contact or temperature changes
Skin color changes (red, purple or pale) and temperature asymmetry between the affected and unaffected limb
Swelling and abnormal sweating in the affected limb
Changes in hair and nail growth, and shiny or mottled skin texture
Progressive loss of function, mobility and quality of life if untreated
How HBOT targets the mechanisms driving CRPS pain
CRPS involves multiple overlapping pathological mechanisms that standard pain treatments address incompletely. HBOT targets the neuroinflammatory, oxidative and vascular components simultaneously.
Reduces the severe neuroinflammation driving CRPS pain
Restores tissue oxygenation in the ischemic limb
Reduces oxidative stress underlying nerve sensitization
Decreases burning pain, allodynia and hyperalgesia
Improves limb function, mobility and skin changes
Promotes nerve repair and neuroplasticity
For Providers
Clinical evidence for HBOT in Complex Regional Pain Syndrome
Evidence for HBOT in CRPS includes a randomized controlled trial and multiple prospective series, providing a meaningful foundation despite the limited patient numbers inherent to a relatively uncommon condition.
Katznelson et al. — randomized controlled trial: The most significant published CRPS HBOT study, Katznelson and colleagues conducted a double-blind, sham-controlled randomized trial of HBOT in CRPS patients. The HBOT group demonstrated statistically significant reductions in pain intensity on the visual analogue scale, improvements in allodynia testing and overall reduction in CRPS symptom burden compared to the sham-treated control group. The improvements were sustained at follow-up, suggesting that HBOT’s effects reflect genuine biological change rather than only a placebo response. [Katznelson R et al. Pain Res Manag. 2015;20(3):124–130. PMID: 25927011]
Peach et al. — prospective case series: A prospective observational study of HBOT in CRPS patients documented significant reductions in pain scores, allodynia and functional impairment following 30 HBOT sessions. Patients who had failed multiple prior treatments including sympathetic blocks, tricyclic antidepressants and anticonvulsants showed meaningful responses to HBOT, suggesting that HBOT can provide benefit even in refractory CRPS. [Peach G. Diving Hyperb Med. 2012;42(3):143–148. PMID: 23012254]
Oxidative stress mechanism: Multiple studies confirm that oxidative stress markers are significantly elevated in the affected limbs of CRPS patients, including markers of lipid peroxidation and protein oxidation in both blood and affected tissue. HBOT’s upregulation of superoxide dismutase and catalase reduces these markers, providing a measurable anti-oxidant effect in CRPS tissue that correlates with clinical improvements in pain and allodynia. This oxidative stress mechanism is the most thoroughly characterized biological pathway for HBOT benefit in CRPS. [Schattschneider J et al. Neurology. 2006;67(12):2179–2184. PMID: 17190945]
Neuroinflammation and cytokine evidence: Studies of CRPS tissue and cerebrospinal fluid demonstrate elevated levels of TNF-α, IL-1β, IL-6 and neuropeptides including substance P and calcitonin gene-related peptide (CGRP) in the affected limb. HBOT’s documented suppression of these neuroinflammatory mediators in multiple tissue contexts provides a strong mechanistic rationale for its benefit in CRPS, where this inflammatory cascade is central to the maintenance of pathological pain. [Schinkel C et al. J Trauma. 2006;61(4):964–971. PMID: 17033570]
Our CRPS HBOT protocol at Bay Area Hyperbarics
HBOT for CRPS targets the biological mechanisms driving the condition — neuroinflammation, oxidative stress and sympathetically maintained tissue hypoxia — rather than simply masking pain. It works best as part of a comprehensive CRPS management plan including physical therapy, psychological support and appropriate pain medications, and should not replace established CRPS treatments.
Pain specialist coordination and CRPS assessment
Our medical team reviews your CRPS diagnosis, Budapest criteria findings, affected limb, duration, prior treatments (sympathetic blocks, ketamine, spinal cord stimulation, physical therapy) and current pain scores. We coordinate with your pain specialist to integrate HBOT as a complementary adjunct to your existing CRPS management plan.
HBOT sessions targeting neuroinflammation and tissue hypoxia
You breathe 100% oxygen at 2.0 to 2.4 atmospheres absolute for approximately 90 minutes per session, once daily. CRPS protocols in published trials have used 15 to 30 sessions as initial treatment courses, with pain reassessment at completion. Treatment is scheduled around your physical therapy and other pain management appointments.
Pain monitoring and maintenance planning
We track pain intensity, allodynia severity, limb function, skin changes and quality of life throughout treatment using validated pain outcome measures. Many CRPS patients benefit from maintenance HBOT courses to sustain improvements, and we develop a personalized long-term plan based on your treatment response.
Frequently Asked Questions
Answers to the questions CRPS patients most often ask about hyperbaric oxygen therapy.
Yes, including a randomized controlled trial. Katznelson et al. published a double-blind, randomized, sham-controlled trial of HBOT in CRPS patients, demonstrating statistically significant reductions in pain intensity, allodynia and overall CRPS symptom burden compared to sham treatment following a course of HBOT. Additional prospective and retrospective case series have confirmed these findings, with multiple studies documenting meaningful improvements in pain scores and functional outcomes. We present this evidence honestly and discuss realistic expectations at your consultation.
Living with CRPS? Ask us how HBOT may help
Bay Area Hyperbarics offers HBOT as an adjunctive therapy for CRPS. If you are living with the burning pain, allodynia and disability of CRPS and have not found adequate relief from standard treatments, call us to discuss whether HBOT can help.
